|
IER3IP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24140031587672E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.86209986003428E-11 |
| Normal-vs-Stage2 |
6.440400E-04 |
| Normal-vs-Stage3 |
1.63880000003669E-06 |
| Normal-vs-Stage4 |
1.144870E-03 |
| Stage1-vs-Stage2 |
5.010400E-01 |
| Stage1-vs-Stage3 |
4.019200E-01 |
| Stage1-vs-Stage4 |
2.063600E-01 |
| Stage2-vs-Stage3 |
9.596400E-01 |
| Stage2-vs-Stage4 |
6.681800E-01 |
| Stage3-vs-Stage4 |
5.736600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46660000202681E-08 |
| Normal-vs-AfricanAmerican |
5.048200E-04 |
| Normal-vs-Asian |
2.25169999999997E-05 |
| Caucasian-vs-AfricanAmerican |
8.774400E-02 |
| Caucasian-vs-Asian |
6.046000E-01 |
| AfricanAmerican-vs-Asian |
2.549200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58220000434639E-08 |
| Normal-vs-Female |
6.42339959000537E-10 |
| Male-vs-Female |
5.561600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.54929957751904E-10 |
| Normal-vs-Age(41-60Yrs) |
6.36889999960921E-07 |
| Normal-vs-Age(61-80Yrs) |
3.75299999966217E-07 |
| Normal-vs-Age(81-100Yrs) |
4.284700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.112000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.834600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.050800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.717400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.183000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.140600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.865840E-01 |
| Classical-VS-Follicular |
8.796400E-02 |
| Classical-VS-Other |
1.048050E-01 |
| Classical-VS-Normal |
3.79229980751461E-10 |
| Tall-VS-Follicular |
1.711570E-02 |
| Tall-VS-Other |
8.500200E-01 |
| Tall-VS-Normal |
1.062000E-02 |
| Follicular-VS-Other |
1.432220E-02 |
| Follicular-VS-Normal |
1.70789999920373E-08 |
| Other-VS-Normal |
9.148200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46269996115223E-09 |
| Normal-vs-N1 |
1.833600E-04 |
| N0-vs-N1 |
1.703190E-01 |
|
|
